Report for: A Multicentre, Randomised, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever (NMN Supplement), an Orally Administered Supplementation in Middle Aged and Older Adults

Title	A Multicentre, Randomised, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever (NMN Supplement), an Orally Administered Supplementation in Middle Aged and Older Adults
Published in	Frontiers in Aging, May 2022
DOI	10.3389/fragi.2022.851698
Pubmed ID	35821806
Authors	Hao Huang

X Demographics

The data shown below were collected from the profiles of 84 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United States	11	13%
United Kingdom	2	2%
Venezuela, Bolivarian Republic of	2	2%
Ghana	1	1%
Brazil	1	1%
Spain	1	1%
Japan	1	1%
Malaysia	1	1%
Canada	1	1%
Other	8	10%
Unknown	55	65%

Type	Count	As %
Members of the public	77	92%
Practitioners (doctors, other healthcare professionals)	4	5%
Science communicators (journalists, bloggers, editors)	2	2%
Scientists	1	1%

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	33	100%

Readers by professional status	Count	As %
Student > Bachelor	6	18%
Student > Ph. D. Student	3	9%
Researcher	3	9%
Professor	3	9%
Other	2	6%
Other	5	15%
Unknown	11	33%

Readers by discipline	Count	As %
Medicine and Dentistry	8	24%
Biochemistry, Genetics and Molecular Biology	6	18%
Agricultural and Biological Sciences	3	9%
Pharmacology, Toxicology and Pharmaceutical Science	2	6%
Nursing and Health Professions	1	3%
Other	2	6%
Unknown	11	33%

A Multicentre, Randomised, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever (NMN Supplement), an Orally Administered Supplementation in Middle…